Filing Flows › Quest Diagnostics (DGX) › Q2 2025
Quest Diagnostics (DGX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 23, 2025
Quest Diagnostics (DGX) reported revenue of $2.8B for the second quarter 2025 (Q2 2025), +15% from a year earlier and +4% from the quarter before. Operating margin was 15.9%, net earnings $282M (10.2% of revenue).
Quest Diagnostics, Q2 2025: revenue $2.8B (+15% year over year), operating margin 15.9%, net earnings $282M, operating cash flow $544M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8B | +4% | +15% |
| Operating profit | $438M | +27% | +23% |
| Net earnings | $282M | +28% | +23% |
| Operating cash flow | $544M | +73% | +51% |
| Free cash flow | $436M | +121% | +63% |
What changed
Revenue was $2.8B in Q2 2025, up 15% year over year and up 4% from the previous quarter. DIS business was the largest line at 98% of revenue. DIS business added $0.37B year over year (up 16%), 101% of the total change. All other operating segments declined 3%.
Operating profit was $0.44B, a 15.9% margin (up 1.1 points year over year). Of the extra revenue versus a year earlier, 23% reached operating profit, above the 15% margin then. Total costs grew 14% against revenue growth of 15%. The fastest-growing cost line was SG&A (+17%). Net earnings were $0.28B, up 23% year over year. The effective tax rate was 24.7%.
Operating cash flow was $0.54B (up 51% year over year), 184% of net income including minority interests. Non-cash charges added back $0.14B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.08B. Capital expenditures of $0.11B left free cash flow of $0.44B.
Questions
What was Quest Diagnostics' revenue in the second quarter 2025?
Quest Diagnostics (DGX) reported revenue of $2.8B for the second quarter 2025 (Q2 2025), +15% from a year earlier and +4% from the quarter before.
Was Quest Diagnostics profitable in the second quarter 2025?
Operating profit was $438M (15.9% of revenue) and net earnings $282M.
Source: Quest Diagnostics 10-Q on SEC EDGAR.